Model Medicines

Model Medicines is an AI-driven pharma & biotech tool that accelerates drug discovery and development. It leverages AI to model chemistry and human biology, focusing on creating life-changing drugs.

Claim this tool

1View

At a glance

Pricing

Likely Not Free

Free tier

API

Skill level

Technical

About

What is Model Medicines?

Model Medicines is an AI-driven company dedicated to building better medicines by innovating at the intersection of data science, biology, and drug development. The platform utilizes AI to model chemistry and human biology, accelerating the discovery and development of life-changing drugs. With 192 compounds and 67 validated assets in disease-relevant cellular models across 12 therapeutic targets, Model Medicines focuses on areas such as virology, oncology, inflammation, and longevity. Their proprietary GALILEO™ and AmesNet™ technologies enable ultra-large virtual screening and agentic AI breakthroughs, leading to the identification of best-in-class potential therapeutics, such as MDL-001, a direct-acting, broad-spectrum antiviral.

Best used for

Ideal for pharmaceutical companies and biotech startups who need to accelerate drug discovery, validate therapeutic assets in cellular models, and leverage AI for ultra-large virtual screening. Especially valuable for developing novel treatments in virology, oncology, inflammation, and longevity.

Common actions

discover drugs

accelerate drug development

model chemistry

analyze biological data

Capabilities

Key features

AI drug discovery
Validated cellular models
Ultra-large virtual screening
Agentic AI breakthroughs
Therapeutic pipeline development

Target Audience

data scientiststartup founder

Integrations

Not yet documented

Pricing & Plans

Likely Not Free

Not publicly disclosed. Check modelmedicines.com for current pricing.

FAQs

What therapeutic areas does Model Medicines focus on?

Model Medicines focuses on several key therapeutic areas, including virology, where they develop next-generation antivirals, and oncology, where they have discovered potential therapeutics for AXL and BRD4 targets. They also explore inflammation and longevity.

What is GALILEO™ and AmesNet™?

GALILEO™ is Model Medicines' platform used to discover compounds and advance assets in cellular models of disease. AmesNet™ is a deep learning model that achieves best-in-class performance in AI-driven Ames mutagenicity prediction, enhancing generalization in this critical area.

How does Model Medicines validate its discoveries?

Model Medicines validates its discoveries through extensive preclinical data readouts and partnerships with leading scientists at top academic and corporate laboratories. Their assets are tested in disease-relevant cellular models across various therapeutic targets.

Trending

Subcategories trending in Wellness & Lifestyle

Clinical & Healthcare Pro Health & Fitness Gaming & Entertainment Mental Wellness Self-Improvement Medical & Symptom Checking

Trending

Also listed in

This tool also appears in

Research & Education › Scientific Computing

Explore

Browse AI tools by category

Content & Design Productivity & Business Coding & Development AI Agents & Automation Research & Education Wellness & Lifestyle Career Development Marketing & Growth Data & Analytics Customer Support & CX Finance E-commerce